Paul England explains the Unified Patent Court (UPC) opt-out: what it does, the procedure and the strategic considerations.
A legal toolkit for life sciences companies and their investors providing access to information on:
Commission Notice on products of essentially biological processes - Jemma Emmerson explains the Commission Notice on the patentability of animals and plants derived from essentially biological processes read more
Colin McCall addresses the general patent issues arising for each of four key activities in which a company may be involved during its lifetime:
Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...